住院年轻成人重型COVID-19及死亡的危险因素:SCCM VIRUS COVID-19注册登记分析
该研究为SCCM VIRUS COVID-19注册登记的回溯性队列分析,纳入2020年3月至2021年4月住院的18-40岁COVID-19患者4,005例(152中心、19国)。危重症定义为死亡与21项预设干预/并发症的复合终点,发生率25%,ICU入住率34.3%,住院死亡率3.2%、ICU死亡率8.3%。多因素分析显示男性(aOR 1.83, 95%CI 1.2-2.6)、肥胖(aOR 1.6, 95%CI 1.1-2.4)及年龄较大与住院死亡相关;上述因素及任何合并症与危重症相关。提示对住院年轻成人应重点识别肥胖、男性及合并症患者。
要点
- 住院18-40岁COVID-19患者中,男性与住院死亡独立相关(aOR 1.83, 95%CI 1.2-2.6)。
- 肥胖与住院死亡独立相关(aOR 1.6, 95%CI 1.1-2.4),该人群肥胖占比42.9%。
- 任何合并症与危重症相关;最常见合并症为高血压(14.5%)和糖尿病(13.7%)。
- 该年轻队列危重症发生率25%、ICU入住率34.3%、住院死亡率3.2%、ICU死亡率8.3%。
- 年龄较大亦与住院死亡相关(p=0.03),多项敏感性分析(仅美国患者、高容量中心)结果相似。
适用人群与场景
- 纳入2020年3月至2021年4月住院的18-40岁COVID-19患者,来自152个中心、19个国家,18.6%为非美国患者。
诊断标准与关键阈值
- 危重症定义为死亡与21项预设干预和并发症的复合终点。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型为回溯性队列研究,基于SCCM VIRUS COVID-19注册登记,纳入4,005例患者(152中心、19国),中位年龄32岁(IQR 27-37),女性51%,西班牙裔29.4%,肥胖42.9%,63.2%有合并症。
- 住院死亡3.2%(129/4,005),ICU死亡8.3%(109/1,313),危重症25%(n=996),ICU入住34.3%(n=1,376)。
- 男性与住院死亡相关(aOR 1.83, 95%CI 1.2-2.6),肥胖与住院死亡相关(aOR 1.6, 95%CI 1.1-2.4),年龄较大与住院死亡相关(p=0.03)。
- 任何合并症与危重症相关;敏感性分析(仅美国患者、高容量中心)显示相似危险因素。
证据类型、等级与局限
- 证据类型为回溯性队列研究(注册登记数据),原文未给出证据等级或推荐强度。
- 局限:回溯性设计、注册登记数据,原文未提及更多局限。
对床旁实践的改变
- 对住院年轻成人COVID-19患者,应关注男性、肥胖及任何合并症,因其与危重症或死亡风险升高相关。
指南或共识出处
- Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS) Coronavirus Disease 2019 Registry
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Even with its proclivity for older age, coronavirus disease 2019 has been shown to affect all age groups. However, there remains a lack of research focused primarily on the young adult population.
OBJECTIVES: To describe the epidemiology and outcomes of coronavirus disease 2019 and identify the risk factors associated with critical illness and mortality in hospitalized young adults.
DESIGN SETTINGS AND PARTICIPANTS: A retrospective cohort study of the Society of Critical Care Medicine's Viral Infection and Respiratory Illness Universal Study registry. Patients 18-40 years old, hospitalized from coronavirus disease 2019 from March 2020 to April 2021, were included in the analysis.
MAIN OUTCOMES AND MEASURES: Critical illness was defined as a composite of mortality and 21 predefined interventions and complications. Multivariable logistic regression was used to assess associations with critical illness and mortality.
RESULTS: Data from 4,005 patients (152 centers, 19 countries, 18.6% non-U.S. patients) were analyzed. The median age was 32 years (interquartile range, 27-37 yr); 51% were female, 29.4% Hispanic, and 42.9% had obesity. Most patients (63.2%) had comorbidities, the most common being hypertension (14.5%) and diabetes (13.7%). Hospital and ICU mortality were 3.2% (129/4,005) and 8.3% (109/1,313), respectively. Critical illness occurred in 25% (n = 996), and 34.3% (n = 1,376) were admitted to the ICU. Older age (p = 0.03), male sex (adjusted odds ratio, 1.83 [95% CI, 1.2-2.6]), and obesity (adjusted odds ratio, 1.6 [95% CI, 1.1-2.4]) were associated with hospital mortality. In addition to the above factors, the presence of any comorbidity was associated with critical illness from coronavirus disease 2019. Multiple sensitivity analyses, including analysis with U.S. patients only and patients admitted to high-volume sites, showed similar risk factors.
CONCLUSIONS: Among hospitalized young adults, obese males with comorbidities are at higher risk of developing critical illness or dying from coronavirus disease 2019.
参考来源
- Tripathi S, Sayed IA, Dapul H, et al. Risk Factors for Critical Coronavirus Disease 2019 and Mortality in Hospitalized Young Adults: An Analysis of the Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS) Coronavirus Disease 2019 Registry. Crit Care Explor. 2021. PMID: 34476401. doi:10.1097/CCE.0000000000000514
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。